Financials Q & M Dental Group (Singapore) Limited
Equities
QC7
SG2E73981531
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 SGD | +4.35% | +2.13% | -5.88% |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 377.1 | 370 | 568.4 | 298.1 | 241.3 | 217.7 | - | - |
Enterprise Value (EV) 1 | 377.1 | 370 | 604.5 | 343.5 | 241.3 | 254.7 | 255.8 | 217.7 |
P/E ratio | 21 x | 18.8 x | 18.7 x | 26.3 x | 20.9 x | 13.1 x | 12.8 x | 11.5 x |
Yield | - | 1.91% | 5.95% | 3.17% | - | 4.17% | 4.62% | 10% |
Capitalization / Revenue | 2.95 x | 2.69 x | 2.76 x | 1.65 x | 1.32 x | 1.15 x | 1.15 x | 1.03 x |
EV / Revenue | 2.95 x | 2.69 x | 2.94 x | 1.9 x | 1.32 x | 1.35 x | 1.35 x | 1.03 x |
EV / EBITDA | - | 12.5 x | 12.1 x | 14.5 x | 9.86 x | 8.62 x | 7.42 x | 6.85 x |
EV / FCF | - | 19.1 x | 14.1 x | 15.2 x | - | 9.6 x | 8.99 x | 8.14 x |
FCF Yield | - | 5.25% | 7.1% | 6.57% | - | 10.4% | 11.1% | 12.3% |
Price to Book | - | 3.06 x | 5.81 x | 3.09 x | - | 2 x | 1.83 x | 2.09 x |
Nbr of stocks (in thousands) | 942,750 | 944,774 | 939,443 | 946,443 | 946,443 | 946,443 | - | - |
Reference price 2 | 0.4000 | 0.3917 | 0.6050 | 0.3150 | 0.2550 | 0.2300 | 0.2300 | 0.2300 |
Announcement Date | 4/15/20 | 2/28/21 | 2/22/22 | 3/1/23 | 2/29/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 128 | 137.6 | 205.6 | 181.2 | 182.7 | 188.6 | 189.7 | 210.8 |
EBITDA 1 | - | 29.63 | 50.12 | 23.61 | 24.48 | 29.56 | 34.47 | 31.8 |
EBIT 1 | - | 26.18 | 45.99 | 18.72 | 19.4 | 24.28 | 24.82 | 26.4 |
Operating Margin | - | 19.02% | 22.37% | 10.33% | 10.62% | 12.87% | 13.08% | 12.52% |
Earnings before Tax (EBT) 1 | - | 22.37 | 46.65 | 14.28 | 13.66 | 19.85 | 20.11 | 21.8 |
Net income 1 | - | 19.7 | 30.47 | 11.31 | 11.52 | 16.73 | 16.73 | 18.57 |
Net margin | - | 14.32% | 14.82% | 6.24% | 6.3% | 8.87% | 8.82% | 8.81% |
EPS 2 | 0.0191 | 0.0208 | 0.0323 | 0.0120 | 0.0122 | 0.0175 | 0.0180 | 0.0200 |
Free Cash Flow 1 | - | 19.41 | 42.93 | 22.58 | - | 26.54 | 28.46 | 26.75 |
FCF margin | - | 14.11% | 20.88% | 12.46% | - | 14.07% | 15% | 12.69% |
FCF Conversion (EBITDA) | - | 65.51% | 85.65% | 95.62% | - | 89.79% | 82.57% | 84.12% |
FCF Conversion (Net income) | - | 98.53% | 140.88% | 199.65% | - | 158.64% | 170.1% | 144.05% |
Dividend per Share 2 | - | 0.007500 | 0.0360 | 0.0100 | - | 0.009600 | 0.0106 | 0.0230 |
Announcement Date | 4/15/20 | 2/28/21 | 2/22/22 | 3/1/23 | 2/29/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 S1 |
---|---|
Net sales 1 | 87.14 |
EBITDA | - |
EBIT | - |
Operating Margin | - |
Earnings before Tax (EBT) | - |
Net income | - |
Net margin | - |
EPS | - |
Dividend per Share | - |
Announcement Date | 8/14/23 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | 36.1 | 45.4 | - | 37 | 38.1 | - |
Net Cash position 1 | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | 0.7206 x | 1.921 x | - | 1.252 x | 1.105 x | - |
Free Cash Flow 1 | - | 19.4 | 42.9 | 22.6 | - | 26.5 | 28.5 | 26.8 |
ROE (net income / shareholders' equity) | - | 16.2% | 27.8% | 11.6% | - | 15.6% | 15.8% | 17.4% |
ROA (Net income/ Total Assets) | - | 6.8% | 11.1% | 6.08% | - | 7.33% | 6.94% | 9.02% |
Assets 1 | - | 289.8 | 275.5 | 186.1 | - | 228.4 | 241.2 | 205.9 |
Book Value Per Share 2 | - | 0.1300 | 0.1000 | 0.1000 | - | 0.1200 | 0.1300 | 0.1100 |
Cash Flow per Share | - | - | 0.0500 | 0.0400 | - | - | - | - |
Capex 1 | - | 6.39 | 7.87 | 11 | - | 6.19 | 6.67 | 6.32 |
Capex / Sales | - | 4.64% | 3.83% | 6.06% | - | 3.28% | 3.51% | 3% |
Announcement Date | 4/15/20 | 2/28/21 | 2/22/22 | 3/1/23 | 2/29/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.88% | 160M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+11.62% | 29.59B | |
-12.71% | 16.73B | |
-2.42% | 16.36B | |
-2.63% | 14.92B | |
-31.58% | 11.77B | |
-0.47% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- QC7 Stock
- Financials Q & M Dental Group (Singapore) Limited